Ouabain | CAS# 630-60-4 | Cardiac steroid

Ouabain
new

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 571527

CAS#: 630-60-4

Description: Ouabain is a cardiac steroid that binds to Na(+), K(+)-ATPase and inhibits its activity. Ouabain increases the force of contraction of heart muscle, stabilizes heart rate, and promotes the growth of cardiac, vascular, and neuronal cells both in vitro and in vivo.

Chemical Structure

Ouabain

CAS# 630-60-4

Instruction

Theoretical Analysis

MedKoo Cat#: 571527
Name: Ouabain
CAS#: 630-60-4
Chemical Formula: C29H44O12
Exact Mass: 584.28
Molecular Weight: 584.660
Elemental Analysis: C, 59.58; H, 7.59; O, 32.84

Price and Availability

Size	Price	Availability	Quantity
100mg	USD 230
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Ouabain; ; Acocantherin; Strodival; NSC 25485; NSC-25485; NSC25485

IUPAC/Chemical Name: 3-(6-Deoxy-alpha-L-mannopyranosyloxy)-1,5,11a,14,19-pentahydroxycard-20(22)-enolide

InChi Key: LPMXVESGRSUGHW-KAPJGFEOSA-N

InChi Code: InChI=1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15?,16+,17+,18+,19?,21+,22-,23+,24+,25-,26+,27?,28+,29-/m0/s1

SMILES Code: O=C1OCC([C@H]2CC[C@]3(O)[C@]4([H])CCC5(O)CC(O[C@H]6[C@@H]([C@@H]([C@H]([C@H](C)O6)O)O)O)CC(O)[C@]5(CO)[C@@]4([H])[C@H](O)C[C@]23C)=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 584.66 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Fuerstenwerth H. On the differences between ouabain and digitalis glycosides. Am J Ther. 2014 Jan-Feb;21(1):35-42. doi: 10.1097/MJT.0b013e318217a609. Review. PubMed PMID: 21642827.

2: Yang YH, Wan Y, Lou H, Xue T, Su P. Relationship between ouabain and asthenozoospermia. J Huazhong Univ Sci Technolog Med Sci. 2014 Feb;34(1):87-90. doi: 10.1007/s11596-014-1236-x. Epub 2014 Feb 6. PubMed PMID: 24496684.

3: Dvela-Levitt M, Ami HC, Rosen H, Shohami E, Lichtstein D. Ouabain improves functional recovery following traumatic brain injury. J Neurotrauma. 2014 Dec 1;31(23):1942-7. doi: 10.1089/neu.2014.3544. Epub 2014 Oct 10. PubMed PMID: 25007121; PubMed Central PMCID: PMC4238276.

4: Ninsontia C, Chanvorachote P. Ouabain mediates integrin switch in human lung cancer cells. Anticancer Res. 2014 Oct;34(10):5495-502. PubMed PMID: 25275046.

5: Lewis LK, Yandle TG, Hilton PJ, Jensen BP, Begg EJ, Nicholls MG. Endogenous ouabain is not ouabain. Hypertension. 2014 Oct;64(4):680-3. doi: 10.1161/HYPERTENSIONAHA.114.03919. Epub 2014 Jul 7. Review. PubMed PMID: 25001271.

6: Ruanghirun T, Pongrakhananon V, Chanvorachote P. Ouabain enhances lung cancer cell detachment. Anticancer Res. 2014 May;34(5):2231-8. PubMed PMID: 24778025.

7: Rana S, Rajakumar A, Geahchan C, Salahuddin S, Cerdeira AS, Burke SD, George EM, Granger JP, Karumanchi SA. Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway. FASEB J. 2014 Oct;28(10):4324-34. doi: 10.1096/fj.14-252684. Epub 2014 Jun 26. PubMed PMID: 24970393; PubMed Central PMCID: PMC4202104.

8: Dvela M, Rosen H, Ben-Ami HC, Lichtstein D. Endogenous ouabain regulates cell viability. Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C442-52. doi: 10.1152/ajpcell.00336.2011. Epub 2011 Oct 26. PubMed PMID: 22031604.

9: Penniyaynen VA, Kipenko AV, Lopatina EV, Krylov BV. Effect of ouabain on growth of skin explants in organotypic culture. Bull Exp Biol Med. 2013 Feb;154(4):419-20. English, Russian. PubMed PMID: 23486569.

10: Padilha AS, Salaices M, Vassallo DV, Batista PR, Siman FD. Hypertensive effects of the iv administration of picomoles of ouabain. Braz J Med Biol Res. 2011 Sep;44(9):933-8. Epub 2011 Aug 19. Review. PubMed PMID: 21956536.

11: Silva E, Soares-da-Silva P. New insights into the regulation of Na+,K+-ATPase by ouabain. Int Rev Cell Mol Biol. 2012;294:99-132. doi: 10.1016/B978-0-12-394305-7.00002-1. Review. PubMed PMID: 22364872.

12: Bai YL, Chu QJ, Li J, Chen YY, Li WJ, Zhang Q. A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice. Eur J Pharmacol. 2012 Nov 5;694(1-3):69-74. doi: 10.1016/j.ejphar.2012.08.004. Epub 2012 Aug 30. PubMed PMID: 22960325.

13: Gomez-Sanchez EP, Foecking MF, Sellers D, Blankenship MS, Gomez-Sanchez CE. Is the circulating ouabain-like compound ouabain? Am J Hypertens. 1994 Jul;7(7 Pt 1):647-50. PubMed PMID: 7946167.

14: Jaiswal MK, Dvela M, Lichtstein D, Mallick BN. Endogenous ouabain-like compounds in locus coeruleus modulate rapid eye movement sleep in rats. J Sleep Res. 2010 Mar;19(1 Pt 2):183-91. doi: 10.1111/j.1365-2869.2009.00781.x. Epub 2009 Oct 28. PubMed PMID: 19878449.

15: Kajimura S, Hirano T, Moriyama S, Vakkuri O, Leppäluoto J, Grau EG. Changes in plasma concentrations of immunoreactive ouabain in the tilapia in response to changing salinity: is ouabain a hormone in fish? Gen Comp Endocrinol. 2004 Jan 1;135(1):90-9. PubMed PMID: 14644648.

16: Kawamura A, Abrell LM, Maggiali F, Berova N, Nakanishi K, Labutti J, Magil S, Haupert GT Jr, Hamlyn JM. Biological implication of conformational flexibility in ouabain: observations with two ouabain phosphate isomers. Biochemistry. 2001 May 15;40(19):5835-44. PubMed PMID: 11341849.

17: Schweigert B, Lafaire AV, Schwarz W. Voltage dependence of the Na-K ATPase: measurements of ouabain-dependent membrane current and ouabain binding in oocytes of Xenopus laevis. Pflugers Arch. 1988 Oct;412(6):579-88. PubMed PMID: 2850533.

18: Vakkuri O, Arnason SS, Joensuu P, Jalonen J, Vuolteenaho O, Leppäluoto J. Radioiodinated tyrosyl-ouabain and measurement of a circulating ouabain-like compound. Clin Chem. 2001 Jan;47(1):95-101. PubMed PMID: 11148183.

19: Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994 May;12(5):549-60. PubMed PMID: 7930555.

20: Di Bartolo V, Balzan S, Pieraccini L, Ghione S, Pegoraro S, Biver P, Revoltella R, Montali U. Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC. Life Sci. 1995;57(15):1417-25. PubMed PMID: 7674832.

Your view history

Ouabain new